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Abstract
AIM: Chronic organ-donor shortage has led to the 
acceptance of steatotic livers for transplantation, despite 
the higher risk of graft dysfunction or nonfunction 
associated with the ischemic preservation period of 
these organs. The present study evaluates the effects of 
trimetazidine (TMZ) on an isolated perfused liver model.
METHODS: Steatotic and non-steatotic livers were 
preserved for 24 h in the University of Wisconsin (UW) 
solution with or without TMZ. Hepatic injury and function 
(transaminases, bile production and sulfobromophthalein 
(BSP) clearance) and factors potentially involved in the 
susceptibility of steatotic livers to ischemia–reperfusion 
(I/R) injury, including oxidative stress, mitochondrial 
damage, microcirculatory diseases, and ATP depletion 
were evaluated.
RESULTS: Steatotic livers preserved in UW solution 
showed higher transaminase levels, lower bile production 
and BSP clearance compared with non-steatotic livers. 
Alterations in perfusion flow rate and vascular resistance, 
mitochondrial damage, and reduced ATP content were 
more evident in steatotic livers. TMZ addition to UW 
solution reduced hepatic injury and ameliorated hepatic 
functionality in both types of the liver and protected 
against the mechanisms potentially responsible for the 
poor tolerance of steatotic livers to I/R.
CONCLUSION: TMZ may constitute a useful approach 
in fatty liver surgery, limiting the inherent risk of steatotic 
liver failure following transplantation.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
The mounting number of  pat ients await ing l iver 
transplantation and the limited pool of  donor organs have 
led to the acceptance of  marginal livers such as steatotic 
livers, for transplantation, despite the higher risk of  graft 
dysfunction or nonfunction which is associated with their 
ischemic preservation[1-3].
There is evidence indicating that the composition 
of  preservation solutions is critical for the quality of  
livers kept for prolonged ischemic periods. University of  
Wisconsin (UW) preservation solution, considered as the 
gold standard of  such solutions, has proved itself  effective 
in preventing liver damage during cold ischemia and has 
extended storage time limits[4,5]. However, irreversible 
injury occurring after prolonged cold periods (between 16 
and 24 h) has also been reported. The main aims of  organ 
preservation, therefore, are striving to prolong organ 
tolerance[6,7].
Trimetazidine (TMZ), introduced as an anti-ischemic 
drug into the heart for over 35 years[8,9], has also been 
used to protect kidneys exposed to the prolonged cold 
ischemia (48 h)[10,11] and is reported to protect liver against 
the deleterious effects of  warm ischemia[12,13]. In addition, 
recently, it has been demonstrated that TMZ pre-treatment 
reduces liver injury and improves liver regeneration 
and survival rate in an experimental model of  partial 
hepatectomy under hepatic blood inflow occlusion[14]. 
Studies examining the underlying protective mechanisms 
of  TMZ suggest that this drug protects mitochondria in 
cardiomyocytes and isolated perfused heart by releasing 
the calcium accumulated in the matrix and by restoring 
mitochondrial membrane impermeability[8,15]. TMZ 
improves energy recovery in vitro and ex vivo in models 
of  myocardial ischemia[8,15] and reduces oxidative stress 
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A Bin the liver under warm ischemia[12]. Additionally, TMZ 
improves microcirculatory alterations in isolated perfused 
rat kidneys[10]. Taken together, these findings suggest that 
mitochondria, energy metabolism, oxidative stress, and 
microcirculation might be important targets through which 
TMZ exerts its cytoprotective effect. Interestingly, severe 
mitochondrial damage[16,17], decreased ATP level[16,18], 
increased reactive oxygen species (ROS) production[19,20], 
and impaired microcirculation[21,22] have also been 
proposed as factors that might leave steatotic livers 
vulnerable to ischemia–reperfusion (I/R) injury. Taking 
these previous observations into account, here we report 
the results of  a study aimed at investigating whether the 
addition of  TMZ to the standard preservation solution 
(UW) protects steatotic liver grafts against the deleterious 
effects of  I/R injury.
MATERIALS AND METHODS
Homozygous (obese, Ob) and heterozygous (lean, Ln) 
Zucker rats (used as reference group), aged 16-18 wk, 
were purchased from Iffa-Credo (L’Arbresle, France)[19,20]. 
In this study we used isolated perfused rat liver. It is a 
useful experimental system for evaluating hepatic function, 
isolated from the influence of  other organ systems, 
undefined plasma constituents, and neural-hormonal 
effects. Hepatic architectures, microcirculation, and bile 
production were preserved in this experimental model[23,24]. 
All procedures were performed under isof luorane 
inhalation anesthesia. This study respected the European 
Union regulations (Directive 86/609 EEC) for animal 
experiments. 
Liver procurement and experimental groups
The surgical technique was performed as described 
elsewhere[25]. After cannulation of  the common bile 
duct, the portal vein was isolated, and the splenic and 
gastroduodenal veins were ligated. The steatotic and non-
steatotic livers were flushed and preserved in cold UW 
solution for 24 h with or without the addition of  TMZ 
(10-6 mol/L). This dose of  TMZ has been shown to be 
beneficial in various experimental models of  I/R[10,26,27]. At 
higher concentration, TMZ exerted no protective effect[28]. 
TMZ was kindly supplied by the Institut de Recherches 
Internationales Servier (Courbevoie, France).
Protocol 1: Effect of TMZ on steatotic liver injury after cold 
ischemia
After 24 h of  cold storage, livers from 16 Zucker rats (8 
Ln and 8 Ob) preserved in UW solution (UW) and livers 
from 16 Zucker rats (8 Ln and 8 Ob) preserved in UW 
solution with TMZ (UW+TMZ) were flushed with Ringer’
s lactate solution. The aliquots of  the effluent flush were 
sampled for the measurements of  cumulative ALT and 
AST after prolonged ischemia.
Protocol 2: Effect of TMZ on steatotic liver injury after 
normothermic reperfusion
After 24 h of  cold preservation, and in order to account 
for the period of  rewarming during surgical implantation 
in vivo[29,30], livers from 16 Zucker rats (8 Ln and 8 Ob) 
preserved in UW solution and livers from 16 Zucker 
rats (8 Ln and 8 Ob) preserved in UW+TMZ solution 
were exposed at 22 ℃ for 30 min prior to reperfusion. 
Livers were then connected via the portal vein to a 
recirculating perfusion system for 120 min at 37 ℃[6,25]. 
Time 0 was the point at which the portal catheter was 
satisfactorily connected to the circuit. As previously 
reported[25,31], during the first 15 min of  perfusion (initial 
equilibration period), the flow was progressively increased 
in order to stabilize the portal pressure at 12 mmHg 
(Pressure Monitor BP-1, Instruments, Inc., Sarasota, FL, 
USA). The flow was controlled using a peristaltic pump 
(Minipuls 3, Gilson, France)[6,25]. The reperfusion liquid 
consisted of  a cell culture medium (William’s medium 
E, BioWhittaker, Spain) with a Krebs-Henseleit-like 
electrolyte composition enriched with 5% albumin, as 
oncotic supply. The buffer was continuously ventilated 
with 95% O2 and 50 mL/L CO2 gas mixture. The buffer 
was subsequently passed through a heat-exchanger (37 ℃) 
and a bubble trap prior to entering the liver[25,30]. During 
120 min of  normothermic reperfusion, the effluent fluid 
was collected at 30 min intervals to measure transaminases. 
After the initial equilibration period of  15 min, flow 
rate and vascular resistance were assessed continuously 
throughout the reperfusion period. Bile output and hepatic 
clearance (expressed as percentage of  BSP in bile samples) 
were determined at 120 min of  reperfusion. ATP, adenine 
nucleotides, and lipid peroxidation were evaluated in the 
liver samples at 120 min of  reperfusion. Light/electron 
microscopy analysis of  the liver was also performed at 120 
min of  reperfusion.
Biochemical determinations
Transaminase assay:  Hepatic injury was evaluated 
according to transaminase levels using commercial kit from 
Boehringer Mannheim (Munich, Germany).
Nucleotide analysis:  Livers were homogenized in 
perchloric acid solution, and the adenine nucleotides 
pool was measured by h igh-per for mance l iqu id 
chromatography[32].
Bile output:  Liver function was assessed by measuring 
bile production[33,34]. Bile was collected through the 
cannulated bile duct and output reported as µL/g liver.
Hepatic clearance:  As with bile output, hepatic 
clearance was considered as another parameter of  hepatic 
function[35,36]. Thirty minutes after the onset of  the 
perfusion (t30), 1 mg of  BSP (Sigma, Spain) was added to 
the perfusate. The concentration of  BSP in bile samples (t120) 
was measured at 580 nm with an UV-visible spectrometer. 
Bile BSP excretion was expressed as a percentage of  
perfusate content (t120 bile/t30 perfusate×100)[35,36].
Flow rate and vascular resistance:  Liver circulation 
was assessed by measuring perfusion f low rate and 
vascular resistance[34,37]. Perfusion flow rate was assessed 
continuously throughout the reperfusion period and 
expressed as mL/min·g. Vascular resistance was defined 
as the ratio of  portal venous pressure to flow rate and 
expressed in mmHg·min·g/mL[34,37].
Lipid peroxidation assay:  Lipid peroxidation was used 
as an indirect measure of  the oxidative injury induced by 
ROS[19,38]. Lipid peroxidation was determined by measuring 
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the formation of  malondialdehyde (MDA) with the 
thiobarbiturate reaction[19].
Light/electron microscopy
For light microscopy examinations, liver samples were 
fixed in 10% neutral buffered formalin and embedded 
in Paraplast, and 5-µm sections were stained with 
hematoxylin and eosin according to standard procedures[19]. 
For electron microscopy, the fixation of  hepatic tissue 
was perfor med us ing a 2 .5% glutara ldehyde/2% 
paraformaldehyde. These samples were post-fixed with 
osmium tetroxide and potassium ferrocyanide, dehydrated 
in acetone, and embedded in Spurr’s medium. Ultrathin 
sections were prepared with an ultracut-E ultramicrotome 
and contrasted with uranyl acetate and lead citrate. Stained 
sections were reviewed under an H 600-AB Hitachi 
electron microscope[39].
Statistics
Data were expressed as mean±SE, and were compared 
statistically by variance analysis, followed by Student-
Newman-Keuls test. P  < 0.05 was considered significant.
RESULTS
Protocol 1: Effect of TMZ on steatotic liver injury after 24 h 
of cold ischemia
Flushing of  livers before reperfusion allowed effluent fluid 
to collect for the determination of  transaminases[6,40]. This 
measure proved to be a valuable tool for predicting organ 
damage after cold preservation[6,40]. As shown in Figure 
1, the higher levels of  transaminases released by steatotic 
livers after cold preservation in UW solution confirm the 
increased sensitivity of  this type of  liver to cold ischemia. 
The addition of  TMZ to UW solution (UW+TMZ) 
reduced transaminase levels in the flushing effluent of  non-
steatotic livers and, in particular in that of  steatotic livers.
Protocol 2: Effect of TMZ on steatotic liver injury after 
24 h of cold ischemia followed by 2 h of normothermic 
reperfusion
Higher perfusate transaminase levels were observed 
in steatotic livers as the reperfusion period progressed 
compared with those found in non-steatotic livers (Figure 
2). The addition of  TMZ to UW solution reduced the 
perfusate transaminase release in both types of  liver, 
but especially in steatotic livers. The histological light 
microscopic study showed a marked disintegration of  
hepatic architecture in both types of  liver preserved in UW 
solution (Figures 3A and 3B), but especially in steatotic 
livers (Figure 3B), whereas in the UW+TMZ group 
hepatocyte integrity was maintained (Figures 3C and 3D).
Liver function was assessed by measuring bi le 
production and BSP clearance. Bile output and the 
percentage of  BSP in bile were lower in steatotic livers 
preserved in UW solution than in non-steatotic livers 
(Figure 4). Both liver function parameters improved 
significantly in the two liver types following the addition 
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Figure 1 AST (A) and ALT (B) levels in flushing effluent after 24-h cold storage. 
UW: liver preserved in UW solution; UW+TMZ: liver preserved in UW with TMZ. 
aP < 0.05 vs UW.
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Figure 2 AST (A) and ALT (B) levels in perfusate after 30, 60, 90, and 120 min 
of normothermic reperfusion. UW: liver preserved in UW solution; UW+TMZ: liver 
preserved in UW with TMZ. aP < 0.05 vs UW.
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of  TMZ to UW solution (UW+TMZ).
The mechanisms by which TMZ was able to protect 
steatotic livers against the deleterious effects of  I/R 
injury were also evaluated. As shown in Figure 5, MDA 
levels during reperfusion increased, particularly in the 
case of  steatotic livers. The addition of  TMZ to UW 
solution (UW+TMZ) brought about a reduction in 
these levels of  increase. Marked increases in the vascular 
resistance and lower perfusion flow rate were observed 
in steatotic livers preserved in UW solution during the 
reperfusion period (t30,60,90,120) compared with the rates 
in non-steatotic livers (Figure 6). The liver weight was 
not statistically significant in both liver types. Vascular 
resistance was lower and perfusion flow rate was higher 
in both types of  liver following the addition of  TMZ to 
UW preservation solution (UW+TMZ). The beneficial 
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Figure 3 Histological change in steatotic and non-steatotic livers after 120 min of 
normothermic reperfusion. Non-steatotic (A) and steatotic (B) livers preserved in 
UW solution: Cell swelling and disintegration of hepatic architecture were more 
evident in steatotic livers. Non-steatotic (C) and steatotic (D) livers preserved in 
UW solution with TMZ: Hepatic morphology was better preserved in both types of 
the liver compared to that recorded in UW solution.
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Figure 4 Bile output (A) and percentage of sulfobromophthalein (BSP) in bile (B) 
of steatotic and non-steatotic livers after 120 min of normothermic reperfusion. 
UW: livers were preserved in UW solution; UW+TMZ: liver preserved in UW with 
TMZ. aP < 0.05 vs UW.
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Figure 5 Hepatic malondialdehyde (MDA) levels after 120 min of normothermic 
reperfusion. UW: liver preserved in UW solution; UW+TMZ: liver preserved in UW 
with TMZ. aP < 0.05 vs UW.
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Figure 6 Vascular resistance (A) and perfusion flow rate (B) of steatotic and non-
steatotic livers after 120 min of normothermic reperfusion. UW: livers were preserved 
in UW solution; UW+TMZ: liver preserved in UW with TMZ. aP < 0.05 vs UW.
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effect of  TMZ on the vascular resistance and perfusion 
flow rate were more evident in the steatotic livers (Figure 
6). Lower ATP and adenine nucleotides levels during 
reperfusion were observed in steatotic livers preserved in 
UW solution than those recorded for non-steatotic livers 
(Figure 7). The results reported here show that TMZ led 
to the preservation of  more ATP and adenine nucleotides 
content in both types of  liver.
Mitochondrial damage was evaluated by electron 
microscopy. Ultra-structural analysis after reperfusion in 
both types of  liver preserved in UW solution revealed 
swelling of  mitochondria, a significant decrease in the 
electron density of  their matrices, while cristae were only 
seldom visible (Figures 8A and 8B). These morphological 
alterations were more evident in steatotic livers (Figure 
8B). Following the addition of  TMZ to UW preservation 
(UW+TMZ) a g rea te r deg ree o f  mi tochondr i a l 
preservation in both types of  liver was recorded (Figures 
8C and 8D) compared to the results obtained for the livers 
in UW solution.
DISCUSSION
The results of  the present study indicate that the addition 
of  TMZ to UW solution improved the capacity of  this 
standard preservation solution in both types of  liver 
subjected to prolonged ischemic period especially in 
steatotic livers.
It is widely accepted that bile analysis is a useful 
means for assessing the integrity of  biliary epithelial cells 
after cold ischemia. If  cold storage time exceeds 10-12 h, 
complications in biliary structures occur in more than 25% 
of  liver transplant recipients[41-43]. Several factors, including 
poor recovery after ATP depletion appear to contribute 
to bile duct cell damage after liver transplantation. 
Furthermore, isolated rat bile duct epithelial cells are 
noticeably sensitive to oxidative stress, possibly because 
their cellular stores of  reduced glutathione are seven 
times lower than those of  hepatocytes[44]. Taking these 
observations into account, bile production failure in 
steatotic livers could be explained, at least partially, by the 
lower ATP and increased oxidative stress presented by 
this type of  liver compared with non-steatotic liver. Liver 
transplantation may benefit from strategies such as the 
addition of  TMZ to the preservation solution as this seems 
to help maintain appropriate bile duct cell functions. Here, 
this strategy increased ATP recovery and reduced oxidative 
stress. This was also associated with better bile production.
The lower perfusate flow rate and the higher resistance 
to flow in steatotic, as opposed to non-steatotic livers 
indicate that steatotic livers offer greater impediments 
to perfusion. Fat accumulation in the cytoplasm of  the 
hepatocytes is associated with an increase in cell volume, 
which may result in the partial or complete obstruction 
of  the hepatic sinusoidal space[3,21]. Our results indicate 
the beneficial effects of  TMZ on the f low rate and 
vascular resistance especially in the steatotic livers which 
were preserved during prolonged cold ischemia. Various 
hypotheses could be forwarded in an attempt at explaining 
the underlying protective mechanisms. In fact, according 
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Figure 7 ATP (A) and adenine nucleotide (B) levels of steatotic and non-steatotic 
livers after 120 min of normothermic reperfusion. UW: livers were preserved in UW 
solution; UW+TMZ: liver preserved in UW with TMZ. aP < 0.05 vs UW.
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Figure 8 Electron microscopy analysis of structural integrity of the mitochondria. 
Non-steatotic (A) and steatotic (B) livers preserved in UW solution: mitochondria 
swelling and the alterations in the electron density of their matrices were more 
evident in steatotic livers. Cristae are only seldom visible in steatotic livers. 
Non-steatotic (C) and steatotic (D) livers preserved in UW solution with TMZ. 
Mitochondrial integrity was better preserved in both types of liver compared to that 
recorded in UW solution.
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to the literature, TMZ reduces the leakage of  intracellular 
potassium, which is a vasoconstrictor; it affects vasoactive 
mediators including prostaglandins; and it reduces tissue 
edema, which has been related to the disturbance of  
microvascular circulation[10,45,46].
Fatty degenerat ion, which induces a ser ies of  
ultrastructural and biochemical alterations both in 
human and animal mitochondria[17,47] may render these 
organelles intrinsically more susceptible to I/R injury. 
Given that mitochondria are the main sites for ATP and 
ROS production in I/R[16], the lower ATP and adenine 
nucleotides content and the increased oxidative stress 
observed in steatotic livers preserved in UW solution 
could be attributed to mitochondrial damage. Thus, the 
identification of  new strategies to prevent mitochondrial 
injury should represent an important research goal in 
attempts to optimize the use of  donor steatotic organs for 
liver transplantation. Our result indicates that the addition 
of  TMZ to UW preservation solution protects against 
mitochondrial damage caused by I/R, preserves more 
ATP and adenine nucleotide content during reperfusion 
and decreases oxidative stress, thus showing a protective 
effect against I/R injury. Taken together, these data suggest 
that mitochondria might be an important target through 
which TMZ exerts its cytoprotective effect. However, the 
underlying mechanisms are still far from being defined and 
other possibilities should not be ruled out. Thus, another 
possible reason for the higher ATP levels that are induced 
by TMZ might be improved microcirculation at the time 
of  reperfusion. This could increase the availability of  
oxygen and, therefore, facilitate ATP production. It is well 
known that failure of  liver perfusion can impair the ability 
of  the steatotic liver to restore ATP levels[16,22,48]. Similarly, 
in addition to mitochondria, the beneficial effects of  TMZ 
on oxidative stress could be exerted on other sources of  
ROS, including endothelial cells[10].
The addition of  TMZ to UW solution ensured that 
steatotic grafts were less susceptible to the mechanisms 
involved in I/R injury including microcirculatory 
diseases, ATP and adenine content, oxidative stress and 
mitochondrial damage. In addition to allopurinol and 
glutathione, TMZ could be another antioxidant that 
should be added to UW solution, considering the benefits 
of  TMZ in terms of  oxidative stress and the difficulties 
for preventing oxidative stress damage in steatotic liver 
by other pharmacological treatments[19,33,49]. The ability 
of  TMZ to protect both types of  the liver is particularly 
attractive since some strategies that are effective in non-
steatotic livers may not be useful in the presence of  
steatosis[19,20,50].
In conclusion, TMZ protected against hepatic injury 
and ameliorated liver function in steatotic and non-
steatotic livers preserved in UW solution. Further studies 
will be required to elucidate whether TMZ is such a 
promising drug for the field of  liver transplantation, and 
if  this pharmacological substance can reduce the inherent 
risk of  steatotic liver grafts for transplantation.
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